Cambridge Investment Research Advisors’s ARS Pharmaceuticals SPRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.52M Buy
87,162
+4
+0% +$70 ﹤0.01% 1642
2025
Q1
$1.1M Hold
87,158
﹤0.01% 1787
2024
Q4
$920K Hold
87,158
﹤0.01% 1937
2024
Q3
$1.26M Buy
+87,158
New +$1.26M ﹤0.01% 1690